product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
MMP-9 (G657) Antibody
catalog :
2270
clonality :
polyclonal
host :
rabbit
conjugate :
nonconjugated
reactivity :
human, mouse
application :
western blot, immunocytochemistry
citations: 12
Published Application/Species/Sample/DilutionReference
  • western blot; human; loading ...; fig 3c
Xu J, Zhang X, Wang H, Ge S, Gao T, Song L, et al. HCRP1 downregulation promotes hepatocellular carcinoma cell migration and invasion through the induction of EGFR activation and epithelial-mesenchymal transition. Biomed Pharmacother. 2017;88:421-429 pubmed publisher
  • western blot; human; 1:1000; loading ...; fig 3c
Gan J, Wang F, Mu D, Qu Y, Luo R, Wang Q. RNA interference targeting Aurora-A sensitizes glioblastoma cells to temozolomide chemotherapy. Oncol Lett. 2016;12:4515-4523 pubmed publisher
  • western blot; human; loading ...; fig 6
Lv M, Li Y, Tian X, Dai S, Sun J, Jin G, et al. Lentivirus-mediated knockdown of NLK inhibits small-cell lung cancer growth and metastasis. Drug Des Devel Ther. 2016;10:3737-3746 pubmed
  • western blot; human; 1:1000
Wang C, Xiang R, Zhang X, Chen Y. Doxycycline inhibits leukemic cell migration via inhibition of matrix metalloproteinases and phosphorylation of focal adhesion kinase. Mol Med Rep. 2015;12:3374-3380 pubmed publisher
  • immunocytochemistry; human
Foronjy R, Taggart C, Dabo A, Weldon S, Cummins N, Geraghty P. Type-I interferons induce lung protease responses following respiratory syncytial virus infection via RIG-I-like receptors. Mucosal Immunol. 2015;8:161-75 pubmed publisher
  • western blot; human; 1:1000; loading ...; fig st3
Rahme G, Israel M. Id4 suppresses MMP2-mediated invasion of glioblastoma-derived cells by direct inactivation of Twist1 function. Oncogene. 2015;34:53-62 pubmed publisher
Tanaka T, Terai Y, Kogata Y, Ashihara K, Maeda K, Fujiwara S, et al. CD24 expression as a marker for predicting clinical outcome and invasive activity in uterine cervical cancer. Oncol Rep. 2015;34:2282-8 pubmed publisher
Su C, Liu Y, Yang C, Lin Y, Chiou J, Chi L, et al. Plasminogen Activator Inhibitor-2 Plays a Leading Prognostic Role among Protease Families in Non-Small Cell Lung Cancer. PLoS ONE. 2015;10:e0133411 pubmed publisher
Sun B, Xu M. Matrine inhibits the migratory and invasive properties of nasopharyngeal carcinoma cells. Mol Med Rep. 2015;11:4158-64 pubmed publisher
Zhang S, Zhu L, Chen H, Zhang R, Zhang P, Jiang D, et al. Interferon regulatory factor 9 is critical for neointima formation following vascular injury. Nat Commun. 2014;5:5160 pubmed publisher
Han F, Zhang J, Shao J, Yi X. Caveolin-1 promotes an invasive phenotype and predicts poor prognosis in large cell lung carcinoma. Pathol Res Pract. 2014;210:514-20 pubmed publisher
Tanney A, Oliver G, Farztdinov V, Kennedy R, Mulligan J, Fulton C, et al. Generation of a non-small cell lung cancer transcriptome microarray. BMC Med Genomics. 2008;1:20 pubmed publisher
product information
SKU :
2270S
Product-Name :
MMP-9 (G657) Antibody
Size :
100 ul
Price-(USD) :
235 USD
Species-x-Reactivity :
H
Applications :
Western blot
Product-Category :
Adhesion/ECM
Shipping-Temp :
AMBIENT
Storage-Temp :
-20°C
Product-Type :
Polyclonal Antibody
MW :
92 kDa
Host :
Rabbit
Target :
MMP9
Primary-Protein :
MMP9
Alt-Names :
67 kDa matrix metalloproteinase-9,82 kDa matrix metalloproteinase-9,92 kDa gelatinase,92 kDa type IV collagenase,CLG4B,GELB,Gelatinase B,MANDP2,MMP-9,MMP9,Matrix metalloproteinase-9,macrophage gelatinase,matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase),matrix metalloproteinase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase),type V collagenase
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.